These findings demonstrate that small-molecule modulation of p75NTR by LM11A-31 both reduces the accumulation of pathological tau species and promotes resilience against oTau-induced dendritic spine degeneration, exemplifying a “dual-mechanism” therapeutic approach for tauopathies. Here, MAPT is linked to tauopathy.